www.aerogen.com Headquartered in Galway, Ireland, Aerogen is the world leader in acute care aerosol drug delivery. With over 25 years of experience, 300 international patents and associated with over 200 clinical papers and publications, Aerogen technology has been used to treat 16 million patients in 75 countries worldwide. Based on pioneering vibrating mesh technology, the Aerogen Solo vibrating mesh nebuliser has become the gold standard for respiratory patient care across the hospital from the emergency department to intensive care. Aerogen’s dynamic R&D team is dedicated to the continuous improvement and development of aerosol drug delivery technology. Innovation and creativity are at the core of every product development programme, while Aerogen’s structured five-stage gate development process ensures that projects are executed in a methodical and cost-effective manner. The company continues to leverage its expertise, research, technologies and partnerships to make the greatest possible difference to patient outcomes. Award-winning technology with over 300 international active and pending patents made us a world leader in acute care aerosol drug delivery. Our technology is a breakthrough in aerosol drug delivery and is at the heart of all our products. FIRM PROFILE CEO Today Healthcare Awards 2023 - IRELAND - - 30 -
RkJQdWJsaXNoZXIy Mjk3Mzkz